Nano Labs Ltd ADR (NA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 09-2024 | 06-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,645 | -16,629 | N/A | -8,299 | -35,912 |
| Depreciation Amortization | 872 | 1,618 | N/A | 765 | 1,437 |
| Accounts receivable | 9 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 841 | N/A | N/A | N/A | N/A |
| Other Working Capital | -2,923 | -8,120 | N/A | -5,024 | 6,933 |
| Other Operating Activity | -4,247 | 3,748 | 0 | 1,788 | 8,697 |
| Operating Cash Flow | $-7,094 | $-19,383 | $N/A | $-10,770 | $-18,845 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 208 | -5,057 | N/A | -4,621 | -14,893 |
| Purchase Of Investment | -279 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 1,103 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -30,662 | 0 | 0 | 0 |
| Investing Cash Flow | $1,032 | $-35,719 | $N/A | $-4,621 | $-14,893 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,964 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 49,876 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -334 | 52,304 | 0 | 11,250 | 28,170 |
| Financing Cash Flow | $52,506 | $52,304 | $N/A | $11,250 | $28,170 |
| Exchange Rate Effect | -197 | 609 | N/A | 681 | 23 |
| Beginning Cash Position | 4,589 | 6,758 | N/A | 6,817 | 12,405 |
| End Cash Position | 50,835 | 4,570 | N/A | 3,357 | 6,859 |
| Net Cash Flow | $46,246 | $-2,189 | $N/A | $-3,460 | $-5,545 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,094 | -19,383 | N/A | -10,770 | -18,845 |
| Capital Expenditure | -84 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -7,177 | -19,383 | 0 | -10,770 | -18,845 |